Tuesday, May 15, 2012

Ono Enters into Drug Discovery Collaboration with Scil Proteins for Affilin® Therapeutics

Ono Pharmaceutical Co., Ltd. announced today that Ono and Scil Proteins GmbH (Halle, Germany) signed a collaboration agreement for joint discovery and development of new protein therapeutics. Under the terms of the agreement, Ono will pay to Scil Proteins research funding, and make milestone payments for research, development and commercialization, and royalty payments based on sales.
Scil Proteins will identify unique proteins that bind certain target molecule(s) provided by Ono taking advantage of its proprietary Affilin® drug discovery platform. Ono will further evaluate biological activities and safety profiles of selected proteins and discover new protein-based drug candidates. Ono will have worldwide exclusive rights to develop and commercialize any pharmaceutical product containing a protein developed through this collaboration.

Source :Ono Pharmaceuticals